ScinoPharm Taiwan and Coland Holdings Establish Strategic Alliance for Oncological Injectable Products for China
5/10/2013 9:40:15 AM
More...
|
ScinoPharm and Foresee Pharmaceuticals Entered Into an Agreement to Establish a Joint Venture for Developing Novel Oncological Peptide Drugs
1/30/2013 9:23:11 AM
More...
|
ScinoPharm to Provide Contract Manufacturing Services for VIVUS, Inc. (VVUS)' Newly-Approved Anti-Obesity Drug, Qsymia™
7/19/2012 10:13:33 AM
More...
|
ScinoPharm Building $37.6 Million Cancer Drug CMO in Tainan
7/3/2012 6:42:36 AM
More...
|
ScinoPharm Invests $37.6 Milliion to Construct Injectable Cancer Drugs Plant
6/29/2012 8:32:24 AM
More...
|
ScinoPharm and National Health Research Institutes (NHRI) Announce Jointly Developed Diabetes Drug Approved for Phase I Clinical Trial
3/23/2012 8:22:18 AM
More...
|
ScinoPharm to Provide CMO Services for New Clinical Data Drug
2/17/2011 9:45:36 AM
More...
|
ScinoPharm to Provide Contract Manufacturing Service for Clinical Data, Inc.'s Newly Approved Antidepressant Drug in the United States
2/8/2011 8:09:21 AM
More...
|
ScinoPharm Reports Final FY2009 Results All-Time Highs for Revenue and Operating Profit
3/25/2010 9:23:38 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) To Sell ScinoPharm Taiwan Stake For $94 Million
3/2/2010 7:22:14 AM
More...
|
|